2024-2025 Neuro-Psychiatry Program participants. Click here to visit the Combined Program -Neuropsychiatry webpage. 

Elizabeth Degrush, MD, assistant professor, and co-director of the neuropsychiatry residency program, graduated from the program in 2017, before joining the department as an associate program director. In 2020, Dr. Degrush moved into the co-director leadership position alongside Kate Daniello, MD, associate professor, and director of the neurology residency program. As co-leaders, the team works toward their goal for trainees to get a broad-based learning in neuropsychiatry.  

Sheldon Benjamin, MD, dual board-certified professor of neurology and psychiatry, initiated the neuropsychiatry residency program at UMass Chan becoming one of the four programs available to BNNP residency candidates across the United States. He co-authored an article in the winter 2024 edition of The Journal of Neuropsychiatry Clinical Neuroscience, Dual Residency Training in Neurology and Psychiatry: History and Current Practice. Through 2020, a total of 1,361 dual certified physicians have been accredited through the American Board of Psychiatry and Neurology (ABPN) since 1935. Dr. Benjamin was one of two dual-boarded program directors of a neuro-psychiatry residency program for the past fifty-five years. Dr. Sheldon began his transition to retirement in October 2024 after serving UMass Chan’s Department of Neurology and Psychiatry since 1997, however his tenure with UMass began in 1986. We are honored he has been a monumental part of our team. 

Taylor Young, MD, graduate of the neuropsych residency program at UMass Chan provieds support as a psychologist in the Cognitive and Behavioral Neurology Clinic. Dr. Young expressed his process to learn about the possibility of following the neuropsychiatry field option was easier for him as he was a part of the UMass Chan Medical School, along with Dr. Benjamin. Dr. Young provides assessments and evaluations as a Cognitive Neurologist for patients with cognitive and memory issues, Alzheimer’s Disease and other related dementias.